Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Important limitations of use:
-
Should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis
-
Has not been studied in patients with a history of pancreatitis